Artificial intelligence (AI) is moving from experimentation into day-to-day healthcare operations. For AI in pharmacy practice, the most important question is no longer simply what AI can do, but how pharmacists can use it safely to reduce administrative burden, strengthen medication-related decisions, and create more time for patient care.
AI is increasingly embedded in pharmacy workflows, serving different functions. Predictive models identify risks and patterns, generative AI summarizes or drafts information, and emerging AI agents can coordinate multistep tasks across approved systems. Used with authoritative clinical content, transparent source attribution, and pharmacist oversight, these technologies can help convert large volumes of data into timely, reviewable insights.
Artificial intelligence is changing clinical decision support from static lookup and alerting functions into a more interactive, evidence-grounded workflow. AI-enabled tools can help pharmacists retrieve and summarize relevant evidence, organize patient-specific factors, prioritize medication-related risks, and explain why an intervention may warrant review. The goal is not autonomous decision-making, but faster access to transparent, traceable information that pharmacists can evaluate in the context of the individual patient.
AI systems are ideal for automating routine processes, and in pharmacy operations AI could support inventory management, streamline manual tasks, and reduce the administrative burden on pharmacists. AI may also support medication management, pharmacy operations, patient communication, and drug development. Across these applications, the potential benefits must always be weighed against safety, regulatory, ethical, and workflow considerations.
Let’s take a look at some potential areas for the use of AI across different sectors of pharmacy practice.
Within clinical practice, AI can help pharmacists organize patient data, identify possible drug interactions, surface dosing considerations, and prioritize cases for review. These tools may support more individualized medication decisions, but their outputs depend on data quality, intended use, local validation, and integration into clinical workflows. Pharmacists must verify recommendations and apply professional judgment before an AI-supported insight influences patient care.
Machine-learning tools are being studied and deployed to analyze real-world evidence and identify patterns associated with patient risk and treatment response. By examining data such as genetic information, medical history, and lifestyle factors, these tools may help pharmacists and other clinicians assess individualized treatment considerations. Emerging approaches such as predictive biomarker matching may also help identify therapies for further review, but their usefulness depends on the quality and representativeness of the underlying data, clinical validation, and expert interpretation.
Used responsibly, AI could help pharmacists spend less time assembling information and more time interpreting evidence, resolving medication-related problems, and communicating with patients and care teams. Its value will depend on whether implementations improve the quality, safety, and efficiency of pharmacy work rather than simply adding another layer of technology.
Pharmacy operations represents another area where AI and automation are moving into practical use. Forecasting tools can support inventory planning, drug shortage management, and purchasing decisions, while centralized dispensing, robotics, computer vision, and intelligent work queues can reduce repetitive work in prescription processing and medication distribution. These capabilities are becoming more important as pharmacy closures, workforce constraints, specialty-drug growth, and rising demand for high-touch therapies place greater pressure on access and operating margins. The strongest implementations use automation to extend pharmacy capacity while routing exceptions, high-risk medications, and complex patient needs to pharmacists.
AI may also help pharmacy teams respond to a faster-moving medication market. Specialty-drug growth, expanding indications for metabolic therapies, biosimilar competition, supply disruptions, and changing payer requirements generate frequent updates across formularies, prior authorization criteria, pricing, and availability. AI-assisted surveillance can help surface relevant changes and prioritize work, but pharmacists still need trusted drug information and clear source traceability to determine what those changes mean for a specific organization or patient.
AI tools, including apps, conversational tools, and chatbots, can enhance patient communication by translating medication information into plain language, providing reminders and adherence check-ins, tracking symptoms, and helping patients recognize when to contact the pharmacy. These tools should protect patient information, use approved content, disclose the use of AI, and provide a clear path to a pharmacist when professional judgment is needed.
AI advancements in deep learning and big data have the potential to transform the pharmaceutical industry by enabling faster and more accurate drug discovery. Today, AI-powered tools can analyze extensive datasets, such as genomic information and clinical trial results, to identify promising drug candidates more efficiently. They may also streamline clinical trials through predictive algorithms that target specific patient groups and optimize designs, saving valuable resources.
Regulatory frameworks for AI use in drug and biological product development emphasize transparency, context-of-use risk assessment, credible evidence, and ongoing attention to safety. These principles can help pharmaceutical development organizations evaluate where AI is appropriate across discovery and development while preserving accountable scientific review.
AI in pharmacy practice is advancing rapidly, but rather than replacing the pharmacist’s role, I believe it augments their capabilities and will change how pharmacy work is organized. Routine information retrieval, documentation, forecasting, and administrative follow-up may increasingly be automated or delegated to AI-enabled workflows. Pharmacists remain accountable for interpreting evidence, resolving ambiguity, managing exceptions, communicating risk, and making patient-specific decisions. Pharmacy technicians may also take on expanded technology-enabled operational responsibilities, allowing the pharmacy team to direct more time toward clinical services and patient access.
Pharmacists bring critical expertise, offering personalized care, years of specialized education, and the human touch needed for person-centered patient interactions. By utilizing AI, pharmacists can reduce repetitive tasks and equip themselves with more meaningful insights, allowing them to dedicate more time to direct patient care, applying empathy in ways AI cannot.
Safe adoption of AI in pharmacy practice requires governance across the AI lifecycle, including appropriate use-case selection, local validation, documented data and evidence sources, defined human oversight, and processes for incidents, updates, and retirement. Privacy and cybersecurity protections, along with continuous monitoring for performance, model drift, and bias, are especially important when AI could influence medication selection, dosing, monitoring, or patient communication.
Human judgment must remain central to patient safety. AI can improve efficiency and help reduce errors, but inaccurate, biased, or misinterpreted outputs could compromise health outcomes. Pharmacists must evaluate AI-generated information in the context of each patient, bridge technology and personalized care, and use these tools responsibly to preserve public health and patient trust.
To unlock AI’s potential, pharmacy teams must develop practical capabilities and effective governance by selecting high-value use cases, involving pharmacists and pharmacy technicians in workflow design, testing tools in real-world settings, and monitoring safety and operational outcomes before scaling.
Education should include AI literacy and distinguish between predictive, generative, and agentic AI. It should also cover effective prompting, source verification, bias, model drift, security, privacy, clinical validation.
With effective governance, and supporting pharmacy teams in achieving AI fluency through education and early involvement, this approach will help them operate at the top of their roles, using technology to augment their expertize, while preserving their essential role: human judgment, accountability, trust, and empathy that remain fundamental to patient care.
Watch this 30-minute candid conversation between Vanderbilt’s Dr. Scott Nelson and Micromedex’s Angela Anderson, exploring how AI is changing clinical practice, decision-making, and patient care.